Dr Charlotte Firth BSc, MSc, PhD

Institute of Cancer and Genomic Sciences
Trial Management Team Leader

Contact details

Telephone: +44 (0)121 414 9242
Email: c.m.firth@bham.ac.uk

Address: Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Charlotte Firth is a Trial Management Team Leader for one of the Children’s Cancer Trials Teams (CCTT) at the Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences.

Qualifications

PhD Immunology, University of Birmingham, 2015
MSc Biomedical Sciences, University of the West of England, 2010
BSc (Hons), Medical Sciences and Humanities. Swansea University 2008

Biography

Charlotte graduated with a BSc (Hons) in Medical Sciences and Humanities from Swansea University in 2008. Following this, she was awarded an MSc in Biomedical Sciences from the University of the West of England. Charlotte completed a PhD in Immunology in the School of Cancer of Sciences, University of Birmingham in 2015.

Charlotte joined the Adult Late Phase Team (B Team) of the Cancer Research UK Clinical Trials Unit at the University of Birmingham in 2015, working on CompARE- a trial in head and neck cancer. Charlotte was promoted to Senior Trial Coordinator in 2017 where she continued to work on CompARE as well as further head and neck cancer trials such as ADePT-DDR and PETNECK 2.

In 2021 Charlotte took on a secondment (maternity cover) as Trial Management Team Leader for the Children’s Cancer Trials Team - C. In 2022, Charlotte took on the role as TMTL for the newly formed Children’s Cancer Trials Team- D portfolio, which includes paediatric neuroblastoma and rhabdomyosarcoma trials.

Teaching

MSc Clinical Trials

Research

ResearchGate Profile

Publications

Love S.B, Cafferty F, Snowdon C, Carty K, Savage J, Pallmann P, Mcpartland L, Brown L, Masters L, Schiavone F, Hague D, Townsend S, Amos C, South A, Sturgeon K, Langley R, Maughan T, James N, Hall E, Kernaghan S, Bliss J, Turner N, Tutt A, Yap C, Firth C, Kong A, Mehanna H, Watts C, Hills R, Thomas I, Coplan M, Bell S, Sebag-Montefiore D, Jones R, Parmar M, Sydes M. (2022) Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units. Trials. 23:747

Firth C, Harrison R, Ritchie S, Wardlaw J, Ferro CJ, Starr JM, Deary IJ, Moss P (2016). Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals. QJM April.12.

Kilgour, A.H., Firth, C., Harrison, R., Moss, P.,Bastin, M.E., Wardlaw., J.M., Deary, I.J., Starr, J. M. (2013) Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly. Immun Ageing. Aug. 13.10 (1)33.

*Gow, A.J, *Firth. C.M., Harrison, R., Starr, J.M., Moss, P.A.H., Deary, I.J. Cytomegalovirus infection and cognitive

abilities in old age. (2013) Neurobiology of Ageing. Jul. 34. (7).1846-52 *joint first author

Bartlett, J.B., Firth, C.M., Phillips, A.C., Moss, P.A.H., Baylis, D., Sydall, H., Sayer A.A., Cooper, C., Lord, J.M. (2012) The age-related increase in low-grade inflammation (inflammaging) is not associated with cytomegalovirus. Aging Cell. Oct. 11 (5) 912-15